Cocrystal Pharma (COCP) Current Leases (2018 - 2026)
Cocrystal Pharma (COCP) posted Current Leases of $343000.0 for Q1 2026, up 2.69% sequentially from $334000.0 in Q4 2025, and up 11.0% YoY from $309000.0 in Q1 2025.
Cocrystal Pharma (COCP) Current Leases (2018 - 2026) Analysis & Trends
Cocrystal Pharma has reported Current Leases for 9 years, with the latest figure at $343000.0 in Q1 2026.
- Quarterly Current Leases rose 11.0% year-over-year to $343000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $343000.0 (up 11.0% YoY) and the FY2025 annual result came in at $334000.0, up 10.96% from the prior year.
- Current Leases climbed to $343000.0 in Q1 2026 per COCP's latest filing, from $334000.0 in the prior quarter.
- Over five years, Current Leases peaked at $343000.0 in Q1 2026 and troughed at $14000.0 in Q3 2022.
- A 5-year average of $231117.6 and a median of $240000.0 in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases plunged 51.72% in 2022, then surged 742.86% in 2023.
- Over 5 years, Current Leases stood at $233000.0 in 2022, then advanced by 3.0% to $240000.0 in 2023, then advanced by 25.42% to $301000.0 in 2024, then grew by 10.96% to $334000.0 in 2025, then advanced by 2.69% to $343000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $343000.0, $334000.0, and $326000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Cocrystal Pharma | 16.13 Mn | 13.81 Mn | - | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 352,000.00 |
| Mar 31, 2026 | 343,000.00 |
| Dec 31, 2025 | 334,000.00 |
| Sep 30, 2025 | 326,000.00 |
| Jun 30, 2025 | 317,000.00 |
| Mar 31, 2025 | 309,000.00 |
| Dec 31, 2024 | 301,000.00 |
| Sep 30, 2024 | 293,000.00 |
| Jun 30, 2024 | 251,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Dec 31, 2023 | 240,000.00 |
| Sep 30, 2023 | 118,000.00 |
| Jun 30, 2023 | 166,000.00 |
| Mar 31, 2023 | 208,000.00 |
| Dec 31, 2022 | 233,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 215,000.00 |
| Dec 31, 2021 | 209,000.00 |
| Sep 30, 2021 | 29,000.00 |